Not sure. Resistance is likely in a tumor setting (given the heterogeneity of tumors) but I assume the mechanisms will be different than inhibitor-induced resistance, which would allow for combination therapy options.
Reposted from
Laura Kiessling
I was just teaching my class about induced proximity including PROTACs. What are the current views about how serious an issue resistance is for clinical applications? #chemicalbiology
Comments